Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.59M Sell
4,406
-415
-9% -$142K 0.08% 259
2026
Q1
$1.7M Sell
4,821
-101
-2% -$36K 0.09% 224
2025
Q4
$1.61M Buy
4,922
+3,353
+214% +$1.06M 0.07% 247
2025
Q3
$443K Hold
1,569
0.04% 362
2025
Q2
$438K Buy
1,569
+88
+6% +$24.9K 0.04% 370
2025
Q1
$461K Sell
1,481
-123
-8% -$36.3K 0.05% 319
2024
Q4
$418K Buy
1,604
+2
+0.1% +$593 0.04% 352
2024
Q3
$516K Sell
1,602
-552
-26% -$181K 0.05% 293
2024
Q2
$673K Sell
2,154
-1,540
-42% -$452K 0.07% 243
2024
Q1
$1.05M Buy
3,694
+711
+24% +$208K 0.13% 143
2023
Q4
$859K Buy
2,983
+141
+5% +$38.4K 0.1% 191
2023
Q3
$764K Sell
2,842
-167
-6% -$41.7K 0.11% 182
2023
Q2
$668K Sell
3,009
-938
-24% -$218K 0.09% 226
2023
Q1
$954K Buy
3,947
+488
+14% +$120K 0.13% 157
2022
Q4
$908K Sell
3,459
-264
-7% -$70.8K 0.13% 160
2022
Q3
$839K Sell
3,723
-1,106
-23% -$268K 0.12% 175
2022
Q2
$1.18M Buy
4,829
+916
+23% +$224K 0.16% 139
2022
Q1
$946K Buy
3,913
+1,281
+49% +$294K 0.1% 223
2021
Q4
$592K Sell
2,632
-113
-4% -$23.8K 0.06% 349
2021
Q3
$584K Sell
2,745
-15
-0.5% -$3.45K 0.06% 335
2021
Q2
$673K Sell
2,760
-15
-0.5% -$3.69K 0.08% 281
2021
Q1
$690K Buy
2,775
+80
+3% +$19.1K 0.09% 245
2020
Q4
$620K Buy
2,695
+23
+0.9% +$5.3K 0.09% 236
2020
Q3
$679K Buy
2,672
+147
+6% +$36.4K 0.12% 186
2020
Q2
$596K Sell
2,525
-141
-5% -$32.2K 0.12% 190
2020
Q1
$541K Buy
+2,666
New +$582K 0.12% 181
2019
Q4
Sell
-3,515
Closed -$680K 483
2019
Q3
$680K Sell
3,515
-214
-6% -$41.1K 0.14% 171
2019
Q2
$687K Sell
3,729
-1,171
-24% -$210K 0.16% 154
2019
Q1
$931K Sell
4,900
-1,295
-21% -$247K 0.23% 112
2018
Q4
$1.21M Buy
6,195
+1,536
+33% +$300K 0.35% 74
2018
Q3
$966K Buy
4,659
+279
+6% +$55K 0.25% 102
2018
Q2
$808K Sell
4,380
-1,774
-29% -$314K 0.23% 115
2018
Q1
$1.05M Sell
6,154
-138
-2% -$25.3K 0.26% 90
2017
Q4
$1.09M Sell
6,292
-259
-4% -$45.8K 0.28% 82
2017
Q3
$1.22M Buy
6,551
+233
+4% +$41.3K 0.41% 54
2017
Q2
$1.09M Buy
6,318
+1,985
+46% +$323K 0.34% 59
2017
Q1
$711K Buy
4,333
+161
+4% +$26.8K 0.28% 88
2016
Q4
$610K Buy
4,172
+329
+9% +$49.5K 0.29% 78
2016
Q3
$641K Buy
3,843
+88
+2% +$14.9K 0.31% 82
2016
Q2
$571K Sell
3,755
-2,309
-38% -$359K 0.3% 80
2016
Q1
$909K Buy
6,064
+2,227
+58% +$331K 0.57% 43
2015
Q4
$623K Buy
3,837
+111
+3% +$17.4K 0.41% 66
2015
Q3
$515K Buy
3,726
+1,843
+98% +$291K 0.36% 73
2015
Q2
$289K Buy
+1,883
New +$302K 0.2% 134

Other funds holding AMGN

Kovack Advisors's AMGN Position: Q2 2026 in Review

Kovack Advisors reduced its Amgen (AMGN) stake by 8.6% in Q2 2026, selling an estimated $142K and leaving 4,406 shares worth $1.59M. The position accounts for 0.08% of the portfolio, ranked #259.

Kovack Advisors first reported a position in AMGN in Q2 2015 and has held it in 44 quarters since. The position peaked at $1.7M in Q1 2026. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Kovack Advisors held 4,406 shares of Amgen worth $1.59M as of Q2 2026.
  • Kovack Advisors sold 415 Amgen shares in Q2 2026, an estimated $142K.
  • Amgen made up 0.08% of Kovack Advisors's portfolio in Q2 2026, its #259 holding.
  • Kovack Advisors first reported a position in Amgen in Q2 2015 and has held it in 44 quarters since.
  • Kovack Advisors's Amgen position peaked at $1.7M in Q1 2026.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Kovack Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.